ICAP executive raises £2.5m from sale
A round-up of the biggest director deals today so far.
ICAP chief operating officer Mark Yallop has raised more that £2.5m from selling around 30% of his stake in the derivatives broker.
He sold 459,000 shares at 551.36p a share. Yallop still owns just over 1.07m shares in ICAP.
Yallop has been chief operating officer since July 2005. He was previously at Deutsche Bank.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Last week ICAP said that increased volatility in financial markets helped it in the run-up to Christmas, with revenues over the three months to December up by 9%, in line with its first half.
"Trading across the group's businesses is in line with our prior forecasts and the guidance given at the half year results in November 2010, at which time we stated that we expected pre-tax profits of between £333m and £357m for the year to March 2011," the firm said.
Top Director Buys
St. Modwen Properties (SMP) Director name: Mr Steve BurkeAmount purchased: 27,628 @ 171.00p Value: £47,244
Top Director Sells
ICAP (IAP) Director name: Mr Mark YallopAmount sold: 459,000 @ 551.36p Value: £2,530,742
SThree (STHR) Director name: Mr Gary EldenAmount sold: 110,723 @ 397.03p Value: £439,604
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published